Serial 98574632
Live / Applied — Examiner's amendment / priority action mailed (as of 03 Nov 2025)
What this means for you
Not registered yet, but its 29 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98574632
- Mark type
- Design / logo
- Filed
- 29 May 2024
- Attorney of record
- John R. Rudolph
Goods and services
- Class 005 — Pharmaceuticals: Prefilled injectable pharmaceutical preparations for the treatment of various medical conditions, namely, Gastroenterological conditions, including ulcerative colitis and Crohn's disease, Neurological conditions, including cluster headache and migraine, Dermatologic conditions, including psoriasis, and Rheumatological conditions, including ankylosing spondylitis and non-radiographic axial spondyloarthritis
Owner
- Eli Lilly and Company, Indianapolis, IN, US
Prior registrations
Prosecution history
- 21 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Nov 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 03 Nov 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 03 Nov 2025 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 03 Nov 2025 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 09 Oct 2025 — ASSIGNED TO EXAMINER
- 24 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jul 2025 — NON-FINAL ACTION E-MAILED
- 17 Jul 2025 — NON-FINAL ACTION WRITTEN
- 16 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE